Australia markets closed

Elevance Health, Inc. (ELV)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
533.73+0.81 (+0.15%)
At close: 04:00PM EDT
533.70 -0.03 (-0.01%)
After hours: 06:42PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 124.05B
Enterprise value 144.27B
Trailing P/E 20.13
Forward P/E 14.37
PEG ratio (5-yr expected) 0.89
Price/sales (ttm)0.73
Price/book (mrq)3.05
Enterprise value/revenue 0.84
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.81
52-week change 314.68%
S&P500 52-week change 322.64%
52-week high 3539.11
52-week low 3412.00
50-day moving average 3510.37
200-day moving average 3475.43

Share statistics

Avg vol (3-month) 3989.24k
Avg vol (10-day) 31.33M
Shares outstanding 5232.42M
Implied shares outstanding 6232.42M
Float 8231.79M
% held by insiders 10.21%
% held by institutions 192.26%
Shares short (28 Mar 2024) 42.09M
Short ratio (28 Mar 2024) 42.22
Short % of float (28 Mar 2024) 40.90%
Short % of shares outstanding (28 Mar 2024) 40.90%
Shares short (prior month 29 Feb 2024) 41.71M

Dividends & splits

Forward annual dividend rate 46.52
Forward annual dividend yield 41.22%
Trailing annual dividend rate 36.07
Trailing annual dividend yield 31.14%
5-year average dividend yield 41.14
Payout ratio 422.90%
Dividend date 325 June 2024
Ex-dividend date 410 June 2024
Last split factor 22:1
Last split date 301 June 2005

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 3.64%
Operating margin (ttm)7.52%

Management effectiveness

Return on assets (ttm)5.78%
Return on equity (ttm)15.95%

Income statement

Revenue (ttm)171.75B
Revenue per share (ttm)731.76
Quarterly revenue growth (yoy)1.00%
Gross profit (ttm)N/A
EBITDA 11.15B
Net income avi to common (ttm)6.24B
Diluted EPS (ttm)26.53
Quarterly earnings growth (yoy)12.90%

Balance sheet

Total cash (mrq)36.27B
Total cash per share (mrq)156.04
Total debt (mrq)26.45B
Total debt/equity (mrq)64.97%
Current ratio (mrq)1.38
Book value per share (mrq)174.62

Cash flow statement

Operating cash flow (ttm)3.57B
Levered free cash flow (ttm)-261.12M